DAWN Q4 2025 Earnings Miss on EPS as PreRevenue Biotech Invests in Pipeline NGVT Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Volume Growth AutoNation Q1 2026 Earnings EPS Beats Estimates Amid Stable Demand BRID Q4 2001 Earnings EPS Falls Short of Estimates Revenue Details Not Disclosed UTZ Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower on Mixed Sentiment MBX Biosciences Inc MBX Q1 2026 Earnings EPS Beat as PreRevenue Biotech Advances Pipeline